Boston Scientific Viking™ Fixed Curve Diagnostic Catheters Singapūra - angļu - HSA (Health Sciences Authority)

boston scientific viking™ fixed curve diagnostic catheters

boston scientific asia pacific pte. ltd. - cardiovascular - intended for temporary intracardiac sensing, recording stimulation and temporary pacing during the evaluation of cardiac arrhythmias.

LUTREPULSE POWDER FOR SOLUTION Kanāda - angļu - Health Canada

lutrepulse powder for solution

ferring inc - gonadorelin acetate - powder for solution - 3.2mg - gonadorelin acetate 3.2mg - gonadotropins and antigonadotropins

LUTREPULSE PWS 0.8MG/VIAL POWDER FOR SOLUTION Kanāda - angļu - Health Canada

lutrepulse pws 0.8mg/vial powder for solution

ferring inc - gonadorelin acetate - powder for solution - 0.8mg - gonadorelin acetate 0.8mg - gonadotropins and antigonadotropins

SEROSTIM POWDER FOR SOLUTION Kanāda - angļu - Health Canada

serostim powder for solution

emd serono, a division of emd inc., canada - somatropin; water - powder for solution - 5mg; 1ml - somatropin 5mg; water 1ml - pituitary

SEROSTIM POWDER FOR SOLUTION Kanāda - angļu - Health Canada

serostim powder for solution

emd serono, a division of emd inc., canada - somatropin; water - powder for solution - 6mg; 1ml - somatropin 6mg; water 1ml - pituitary

YAZ PLUS TABLET Kanāda - angļu - Health Canada

yaz plus tablet

bayer inc - drospirenone; ethinyl estradiol; levomefolate calcium; levomefolate calcium - tablet - 3.00mg; 0.02mg; 0.451mg; 0.451mg - drospirenone 3.00mg; ethinyl estradiol 0.02mg; levomefolate calcium 0.451mg; levomefolate calcium 0.451mg - contraceptives

YASMIN PLUS TABLET Kanāda - angļu - Health Canada

yasmin plus tablet

bayer inc - drospirenone; levomefolate calcium; levomefolate calcium; ethinyl estradiol - tablet - 3.0mg; 0.451mg; 0.451mg; 0.03mg - drospirenone 3.0mg; levomefolate calcium 0.451mg; levomefolate calcium 0.451mg; ethinyl estradiol 0.03mg - contraceptives

Rivacor 5 HF-T QP - Biventricular pacemaker/defibrillator Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

rivacor 5 hf-t qp - biventricular pacemaker/defibrillator

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber rate adaptive icd, with is4 port connecting a quadripolar lv lead, home monitoring functions, max. shock of 40j and df4/is4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. ellipsoid shape facilitates implanting in the pectoral muscle area. connections for bipolar pacing, sensing, unipolar connections and shock delivery are in the header. mr conditional. rivacor 5 hf-t qp belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt

Rivacor 7 HF-T - Biventricular pacemaker/defibrillator Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

rivacor 7 hf-t - biventricular pacemaker/defibrillator

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber, rate adaptive icd with home monitoring functions, max. shock energy 40j and df4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. the ellipsoid shape facilitates implantation in the pectoral muscle area. the connections for bipolar pacing, sensing, unipolar connections and shock delivery are found in the device header. mr conditional. rivacor 7 hf-t belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt) through antitachycard

Rivacor 5 HF-T - Biventricular pacemaker/defibrillator Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

rivacor 5 hf-t - biventricular pacemaker/defibrillator

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber rate adaptive icd, with home monitoring functions, max. shock of 40j and df4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. ellipsoid shape facilitates implanting in the pectoral muscle area. connections for bipolar pacing, sensing, unipolar connections and shock delivery are found in the header. mr conditional. rivacor 5 hf-t belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt) through antitachycardia pacing (atp); in c